Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Established in 2011 and headquartered in Miami, Florida, EHAVE, Inc. is a healthcare company concentrating on the development of medical psychedelics and an integrated mental health data platform. This platform is designed to work with both the company's proprietary and third-party digital assessment and therapeutic applications, primarily in Canada. EHAVE provides clinically validated digital rehabilitation and assessment software for patients, including its MegaTeam and Ninja Reflex products. Furthermore, it adapts various custom and third-party clinically proven digital solutions to enhance patient engagement and data modeling. A significant offering is the Ehave Dashboard, a mental health informatics platform that empowers clinicians to make objective, data-driven decisions through insights powered by blockchain technology. The company also offers a platform enabling medical practitioners to deliver healthcare services to patients in their homes. Its comprehensive technology solutions are utilized by clinicians, patients, researchers, pharmaceutical firms, and payors.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overvalued on P/FCF.